{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:23:15Z","timestamp":1793960595728,"version":"4.8.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.vascn.2008.12.004","type":"journal-article","created":{"date-parts":[[2009,5,9]],"date-time":"2009-05-09T04:28:14Z","timestamp":1241843294000},"page":"79-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Validation of the normal, freely moving G\u00f6ttingen minipig for pharmacological safety testing"],"prefix":"10.1016","volume":"60","author":[{"given":"Michael","family":"Markert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Stubhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Trautmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Klumpp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Schuler-Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Guth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"SUPPL.","key":"10.1016\/j.vascn.2008.12.004_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jelectrocard.2004.08.004","article-title":"Arrhythmogenic mechanisms of QT prolonging drugs: Is QT prolongation really the problem?","volume":"37","author":"Antzelevitch","year":"2004","journal-title":"Journal of Electrocardiology"},{"key":"10.1016\/j.vascn.2008.12.004_bib2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2165\/00003495-199957030-00007","article-title":"Moxifloxacin","volume":"3","author":"Balfour","year":"1999","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.vascn.2008.12.004_bib3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/clpt.1984.140","article-title":"Effects of propranolol and of verapamil on heart rate and blood pressure in hyperthyroidism","volume":"36","author":"Clozel","year":"1984","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.vascn.2008.12.004_bib4","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1067\/mcp.2000.111482","article-title":"Effect of a single oral dose of moxifloxacin (400\u00a0mg and 800\u00a0mg) on ventricular repolarization in healthy subjects","volume":"68","author":"Demolis","year":"2000","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.vascn.2008.12.004_bib5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0065-7743(04)39024-X","article-title":"Pre-clinical assessment of drug-induced QT interval prolongation. Current issues and impact on drug discovery","volume":"39","author":"Fermini","year":"2004","journal-title":"Annual Reports in Medicinal Chemistry"},{"issue":"3","key":"10.1016\/j.vascn.2008.12.004_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.vascn.2004.02.006","article-title":"Developing a strategy for the nonclinical assessment of proarrhythmic risk of pharmaceuticals due to prolonged ventricular repolarization","volume":"49","author":"Guth","year":"2004","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2008.12.004_bib7","series-title":"The nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals (S7B)","author":"ICH","year":"2005"},{"issue":"5","key":"10.1016\/j.vascn.2008.12.004_bib8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1254\/jphs.QT-C13","article-title":"QT PRODACT: Usability of miniature pigs in safety pharmacology studies: Assessment for drug-induced QT interval prolongation","volume":"99","author":"Kano","year":"2005","journal-title":"Journal of Pharmacological Sciences"},{"issue":"2","key":"10.1016\/j.vascn.2008.12.004_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.vascn.2006.03.010","article-title":"Optimizing the experimental environment for dog telemetry studies","volume":"54","author":"Klumpp","year":"2006","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2008.12.004_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF00637569","article-title":"Propranolol pharmacokinetics and pharmacodynamics after single dose and at steady state","volume":"33","author":"Lalonde","year":"1987","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1016\/j.vascn.2008.12.004_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.vascn.2004.03.006","article-title":"A novel propellant-free inhalation drug delivery system for cardiovascular drug safety evaluation in conscious dogs","volume":"50","author":"Markert","year":"2004","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"2","key":"10.1016\/j.vascn.2008.12.004_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.vascn.2007.03.004","article-title":"The value added by measuring myocardial contractility \u2018in vivo\u2019 in safety pharmacological profiling of drug candidates","volume":"56","author":"Markert","year":"2007","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2008.12.004_bib13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1055\/s-0038-1633895","article-title":"Correcting the QT interval for changes in HR in pre-clinical drug development","volume":"43","author":"Meyners","year":"2004","journal-title":"Methods of Information in Medicine"},{"issue":"2","key":"10.1016\/j.vascn.2008.12.004_bib14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.vascn.2006.05.002","article-title":"Safety pharmacology in focus: New methods developed in the light of the ICH S7B guidance document","volume":"54","author":"Pugsley","year":"2006","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"1","key":"10.1016\/j.vascn.2008.12.004_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0008-6363(02)00846-5","article-title":"Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: Evidence for a provisional safety margin in drug development","volume":"58","author":"Redfern","year":"2003","journal-title":"Cardiovascular Research"},{"issue":"2","key":"10.1016\/j.vascn.2008.12.004_bib16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00002018-200528020-00003","article-title":"Drugs, QT interval prolongation and ICH E14: The need to get it right","volume":"28","author":"Shah","year":"2005","journal-title":"Drug Safety"},{"key":"10.1016\/j.vascn.2008.12.004_bib17","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.vascn.2008.02.001","article-title":"Evaluation of cardiovascular and ECG parameters in the normal, freely moving G\u00f6ttingen minipig","volume":"57","author":"Stubhan","year":"2008","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2008.12.004_bib18","doi-asserted-by":"crossref","first-page":"H490","DOI":"10.1152\/ajpheart.00046.2007","article-title":"Autonomic effects on QT\u2013RR interval dynamics after exercise","volume":"294","author":"Sundaram","year":"2008","journal-title":"American Journal of Physiology Heart and Circulatory Physiology"},{"issue":"10 I","key":"10.1016\/j.vascn.2008.12.004_bib19","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1540-8159.1997.tb06078.x","article-title":"Is dispersion of ventricular repolarization rate dependent?","volume":"20","author":"Zabel","year":"1997","journal-title":"PACE \u2014 Pacing and Clinical Electrophysiology"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871909002330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871909002330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T23:54:22Z","timestamp":1761004462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871909002330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S1056871909002330"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2008.12.004","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of the normal, freely moving G\u00f6ttingen minipig for pharmacological safety testing","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2008.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}